Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Absci Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABSI
Nasdaq
2836
www.absci.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Absci Corporation
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
- Sep 11th, 2026 6:29 pm
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
- Sep 3rd, 2026 6:55 am
Absci to Participate in Upcoming Investor Conferences
- Sep 1st, 2026 6:00 am
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade
- Aug 30th, 2026 9:21 pm
Absci (ABSI) Q2 2026 Earnings Call Transcript
- Aug 19th, 2026 7:52 am
AMD’s $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next
- Aug 18th, 2026 3:07 pm
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
- Aug 18th, 2026 1:43 am
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
- Aug 17th, 2026 7:56 am
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates
- Aug 16th, 2026 11:01 pm
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation
- Aug 12th, 2026 11:11 am
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?
- Aug 12th, 2026 1:10 am
Absci Corporation Q2 2026 Earnings Call Summary
- Aug 11th, 2026 6:22 pm
Absci Q2 Earnings Call Highlights
- Aug 11th, 2026 4:04 pm
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
- Aug 11th, 2026 2:05 pm
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
- Aug 11th, 2026 12:00 pm
Recursion Pharmaceuticals Q2 Earnings Call Highlights
- Aug 5th, 2026 1:04 pm
Are Medical Stocks Lagging ABSCI CORP (ABSI) This Year?
- Jul 30th, 2026 7:40 am
Scroll